TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmatech AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
35,751
|
36,451
|
33,485 |
| Financial expenses |
254
|
820
|
331 |
| Earnings before taxes |
1,984
|
701
|
-162 |
| Total assets |
10,592
|
10,832
|
9,568 |
| Current assets |
9,321
|
9,917
|
8,677 |
| Current liabilities |
7,307
|
6,433
|
7,619 |
| Equity capital |
2,717
|
1,901
|
1,949 |
| - share capital |
42
|
44
|
47 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
25.7%
|
17.5%
|
20.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
5.5%
|
1.9%
|
-0.5% |
| Return on assets (ROA) |
21.1%
|
14.0%
|
1.8% |
| Current ratio |
127.6%
|
154.2%
|
113.9% |
| Return on equity (ROE) |
73.0%
|
36.9%
|
-8.3% |
| Change turnover |
1,162
|
5,094
|
397 |
| Change turnover % |
3%
|
16%
|
1% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.